USA

Drugs, already approved to treat multiple sclerosis, block HIV infection and transmission in human immune cells

An immunomodulatory drug called fingerolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published August 13 in the open-access journal PLOS Pathogens by Postdoctoral Fellow Rachel Resop and assistant professor Alberto Bosque of …

Read More »